Evercore ISI Group Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $20

Benzinga Newsdesk www.benzinga.com Neutral 53.4%

Neg 0% Neu 53.4% Pos 0%

Evercore ISI Group analyst Daniel Markowitz initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating and announces Price Target of $20.